About this Grant
A 3-year Ontario pilot program that accelerates public funding of select high-priority cancer drugs, providing eligible patients with coverage up to 9 months faster. The program covers drugs after a positive recommendation from Canada's Drug Agency but before pan-Canadian Pharmaceutical Alliance...
Sign up to read more